Inventor · disambiguated record
Axel Mescheder
Also filed as: MESCHEDER AXEL
6 granted patents·2 pending applications·10 citations·filing 2006–2022
76Inventor score
Files withSYNCORE BIOTECHNOLOGY CO LTD3KLICHE KAY-OLIVER2MEDIGENE AG1MESCHEDER AXEL1SYNOX THERAPEUTICS UK LTD1
Top patents by PatentIndex Score
8 records- 0176US8168216B2Treatment of triple receptor negative breast cancerKLICHE KAY-OLIVER·Filed 2007·Granted May 1, 2012·4 cites·13 claims
- 0273US9144563B2Treatment of triple receptor negative breast cancerKLICHE KAY-OLIVER·Filed 2012·Granted Sep 29, 2015·3 cites·23 claims
- 0367US9827196B2Method of administering a cationic liposomal preparationSYNCORE BIOTECHNOLOGY CO LTD·Filed 2015·Granted Nov 28, 2017·2 cites·31 claims
- 0466US9707204B2Treatment of breast cancerSYNCORE BIOTECHNOLOGY CO LTD·Filed 2015·Granted Jul 18, 2017·1 cites·24 claims
- 0560US12454573B2Dosages of emactuzumabSYNOX THERAPEUTICS UK LTD·Filed 2022·Granted Oct 28, 2025·0 cites·5 claims
- 0650US2009317456A1Use of oncolytic viruses and antiangiogenic agents in the treatment of cancerMEDIGENE AG·Filed 2007·Application pending·0 cites
- 0750US2017273934A1Treatment of Triple Receptor Negative Breast CancerSYNCORE BIOTECHNOLOGY CO LTD·Filed 2017·Application pending·0 cites
- 0842US9233094B2Method of administering a cationic liposomal preparationMESCHEDER AXEL·Filed 2006·Granted Jan 12, 2016·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Axel Mescheder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →